Maintenance of high proteolipid protein level in adult central nervous system myelin is required to preserve the integrity of myelin and axons.
Animals
Axons
/ metabolism
Central Nervous System
/ cytology
Cytokines
/ genetics
Estrogen Antagonists
/ pharmacology
Gene Expression
/ drug effects
Gene Expression Regulation
/ drug effects
Immunohistochemistry
Leukocytes, Mononuclear
/ metabolism
Mice
Mice, Inbred C57BL
Mice, Transgenic
Microscopy, Electron, Transmission
Myelin Proteins
/ genetics
Myelin Proteolipid Protein
/ genetics
Myelin Sheath
/ metabolism
Nerve Tissue Proteins
/ genetics
RNA, Messenger
/ metabolism
Tamoxifen
/ pharmacology
glia-axonal support
myelin turnover
neuropathology
oligodendrocyte
proteolipid protein (PLP)
spastic paraplegia
tamoxifen
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
10
07
2018
revised:
24
09
2018
accepted:
01
10
2018
pubmed:
15
1
2019
medline:
14
6
2019
entrez:
15
1
2019
Statut:
ppublish
Résumé
Proteolipid protein (PLP) is the most abundant integral membrane protein in central nervous system (CNS) myelin. Expression of the Plp-gene in oligodendrocytes is not essential for the biosynthesis of myelin membranes but required to prevent axonal pathology. This raises the question whether the exceptionally high level of PLP in myelin is required later in life, or whether high-level PLP expression becomes dispensable once myelin has been assembled. Both models require a better understanding of the turnover of PLP in myelin in vivo. Thus, we generated and characterized a novel line of tamoxifen-inducible Plp-mutant mice that allowed us to determine the rate of PLP turnover after developmental myelination has been completed, and to assess the possible impact of gradually decreasing amounts of PLP for myelin and axonal integrity. We found that 6 months after targeting the Plp-gene the abundance of PLP in CNS myelin was about halved, probably reflecting that myelin is slowly turned over in the adult brain. Importantly, this reduction by 50% was sufficient to cause the entire spectrum of neuropathological changes previously associated with the developmental lack of PLP, including myelin outfoldings, lamellae splittings, and axonal spheroids. In comparison to axonopathy and gliosis, the infiltration of cytotoxic T-cells was temporally delayed, suggesting a corresponding chronology also in the genetic disorders of PLP-deficiency. High-level abundance of PLP in myelin throughout adult life emerges as a requirement for the preservation of white matter integrity.
Substances chimiques
Cytokines
0
Estrogen Antagonists
0
Myelin Proteins
0
Myelin Proteolipid Protein
0
Nerve Tissue Proteins
0
Plp1 protein, mouse
0
RNA, Messenger
0
Tamoxifen
094ZI81Y45
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
634-649Subventions
Organisme : European Research Council
Pays : International
Informations de copyright
© 2019 Wiley Periodicals, Inc.